The largest database of trusted experimental protocols

Nod scid il2rγ null mice

Manufactured by Jackson ImmunoResearch
Sourced in United States, Montenegro

NOD/SCID/IL2Rγ-null mice are an immunodeficient mouse strain that lacks mature T cells, B cells, and NK cells. This strain is commonly used in xenograft and cell transplantation studies.

Automatically generated - may contain errors

32 protocols using nod scid il2rγ null mice

1

Lentiviral Transduction of PDX Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral vector FUW-Luc-mCherry-puro lentivirus (FmC) used in this study, encoding Firefly luciferase and mCherry (from Dr. Andrew Kung, Columbia University) was packaged in 293T cells using a helper virus-free packaging system. Optimal conditions for successful luciferization were established individually for each PDX model (Supplemental Table 1). In general, ascites from established PDX models were implanted intraperitoneally in NOD-SCID IL2Rγnull mice (NSG, Jackson Laboratory) after a comparative DF14-Luc tumor growth rate study demonstrated that latency and growth rates were superior in NSG mice, as compared to SCID or irradiated nude mice (data not shown). Fresh ascites-derived tumor cells from these PDX tumor-bearing NSG mice were then plated ex vivo. They were transduced with FmC Lentiviral vector at a multiplicity of infection of ~10 in medium containing polybrene at 8 µg/ml and selected in puromycin-containing media for 5 to 7 days. The selected cells, once confirmed to be expressing RFP by fluorescent microscopy (Leica) were directly injected into NSG mice intraperitoneally and further expanded (Supplemental Figure 1, Schema). Luciferized PDX models were then further expanded (to a maximum of six passages), banked, characterized, and utilized for drug efficacy and biomarker evaluation studies.
+ Open protocol
+ Expand
2

Establishing Glioblastoma Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOD/SCID-IL2Rγnull mice (No. 005557; The Jackson Laboratory©, United States) of 25 g were anesthetized [ketamine (100 mg/kg)/xylazine (10 mg/kg) via intraperitoneal] and inoculated subcutaneously with 1 × 105 U87MG-GSCs at the left flank. Mice were maintained under standard laboratory conditions of 12 h light-dark cycle, with food and water ad libitum according the Institutional Animal Care and Use committee at the Universidad Austral de Chile. 17 day’s post-inoculation, mice were euthanized with Sodium Thiopental (120 mg/kg via intravenous) and subcutaneous tumors were removed and fixed for histopathological analysis.
+ Open protocol
+ Expand
3

Establishing Merkel Cell Carcinoma Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunodeficient NOD/SCID/IL2r-γnull mice (strain #5557) were generated by Jackson Laboratories (Bar Harbor, ME) and their genetic and immunological characteristics published [71 (link)]. Five-week old female NSG mice were purchased periodically and maintained in the university animal facility. All animal experiments were performed under a protocol approved by the university's Institutional Animal Care and Use Committee, in accordance with NIH guidelines. MCC cells were prepared from logarithmically growing stock cultures by suspending 2 × 107 cells in 80 μl of media + 120 μl of Matrigel (BD Biosciences, San Jose, CA) and injection sites were prepared by shaving and sterilization with alcohol wipes. Mice received subcutaneous injections of primary human MCC cells on right rear flanks and palpable tumor growth appeared within ∼7 days of inoculation, and treatment protocol began when tumors reached approximately 100 mm3 in volume.
+ Open protocol
+ Expand
4

Orthotopic Breast Tumor Metastasis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor growth and spontaneous metastasis formation assayed by injecting tumor cells orthotopically into inguinal mammary fat pads (6- to 8-week-old female NOD/SCID/IL2Rγ-null mice) (Jackson Laboratory, Bar Harbor, ME, USA). Mice anesthetized with isoflurane, injected with 1.5 × 105 cells in Hank's Balanced Salt Solution (Gibco); killed 6±0.5 weeks post injection; tumors dissected, weighed, flash frozen, stored (−80 °C) or fixed: 3.8% formaldehyde, imaged with a fluorescence microscope, and embedded in paraffin and sectioned. Lungs were collected, fixed: 3.8% formaldehyde, embedded in paraffin, sectioned and stained with hematoxylin and eosin (H&E). ZsGreen-positive foci were counted in left pulmonary lobe using ImageJ.
+ Open protocol
+ Expand
5

Pseudoislet Transplantation in NOD Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human pseudoislets were transduced and cultured as described above. Batches of 300 pseudoislets were resuspended in cold Matrigel and transferred into the left renal capsular space of host animals using a glass micro-capillary tube. Transplant recipients were 8-week-old male NOD scid IL2Rγnull mice (stock number 005557; The Jackson Laboratory) and were anesthetized using ketamine/xylazine. Appropriate depth of anesthesia was confirmed by lack of toe-pinch response. One-month post-transplantation, mice were administered an intraperitoneal glucose injection at a dosage of 3 g/kg body weight. Glucose measurements and blood samples were collected via the tail vein at 0, 15, 30, 45, 60, 120, and 180 min post glucose injection. Human insulin is distinguishable from mice insulin, which allowed us to measure its levels by a human insulin ELISA kit (Mercodia).
+ Open protocol
+ Expand
6

In Vivo Tumor Growth Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments have been pre-approved by the University of Southern
California Institutional Animal Care and Use Committee (IACUC). Tumor growth
studies were performed as described previously (10 (link)). Briefly, three million BCPAP-Ctr and BAPAP-Prx cells were
subcutaneously injected into the left and right back skin area of NOD-SCID
IL2Rγnull mice (the Jackson Laboratory). While mice in the control group
(n = 4) were housed with normal drinking water, the treated group (n = 5) were
provided with Dox-containing drinking water from day 1 (2 mg/mL in 5%
sucrose water). After 28 days, tumors were harvested to measure their wet
weights and analyzed for their histology.
+ Open protocol
+ Expand
7

In vivo CRISPR knockdown of SOX2 enhancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo experiments, A673 and SKNMC cells were infected with lentiviral vectors expressing dCas9-KRAB and sgRNAs targeting either the GFP sequence (control) or the GGAA repeat enhancer identified near the SOX2 locus. After 48 h of puromycin selection, 1 × 106 cells for each condition were injected subcutaneously into NOD-scid IL2Rγnull mice (The Jackson Laboratory). Mice were monitored daily for tumor development and sacrificed 3 wk later, when tumor weight and volume were assessed. Experimental protocols involving mice were approved by the Veterinary Service of the Canton of Vaud, Switzerland (Etat de Vaud, Service Vétérinaire), under authorization number VD2488. Statistical analyses were performed by Student's t-test.
+ Open protocol
+ Expand
8

Evaluating Tumour Growth and Metastasis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice were maintained under specific pathogen-free conditions and experimental procedures were performed according to the institutional animal welfare guidelines approved by Institutional Animal Care and Use Committee for the University of Kansas Medical Center.
For subcutaneous tumour growth assays, cells were dissociated into single-cell suspensions using non-enzymatic cell dissociation solution (Sigma Biochemicals) and numbers of live cells were counted following trypan blue staining (Thermo Fisher Scientific). Cell suspension in 50 μl of 4.5 mg ml−1 Matrigel (BD Biosciences) in Hank's balanced salt solution was subcutaneously injected into flanks of NIH-III nude mice (Charles River). Tumours were measured three dimensionally two to three times a week for 17–20 days. For tail vein assays, 150 μl of cell suspension (5 × 104) was injected into the lateral veins of nude mice. Mice were monitored for laboured breathing and the numbers of pulmonary tumour nodules were evaluated 6 weeks after injections. For orthotopic injections, 15 μl of cell suspension (1 × 105) was injected into femoral bone marrow space of anaesthetized NOD-scid IL2Rγnull mice (The Jackson Laboratories)22 (link). When the tumours reached ∼1 cm in thigh diameter, the mice were killed. The weight of the primary tumours and numbers of tumour nodules in the lungs and liver (>0.5 mm) were measured.
+ Open protocol
+ Expand
9

In vivo Efficacy of Compound 14 Against Malaria

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vivo efficacy of 14 was
measured against P. falciparumPf3D70087/N9 growing in the peripheral
blood of NOD-scidIL2Rγnull mice (Jackson Laboratory,
USA) (23–36 g) engrafted with human erythrocytes as described.47 (link) Human biological samples were sourced and used
in accordance with the terms defined in the informed consent of the
IRB/EC-approved protocol. The parasites (20 × 106)
were inoculated by intravenous injection, and antimalarial efficacy
was assessed using a standard “4-day test”. Blood parasitemia
was measured by FACS analysis. Compound 14 was administered
in vehicle (1% methylcellulose) by oral gavage QD for four consecutive
days starting on the third day after infection. The actual administered
doses were determined by the measurement of the formulation concentrations.
The compound concentrations in either the formulations or the blood
from the infected mice were measured by LC–MS–MS (described
above). The efficacy markers (ED90, AUCED90)
were determined on the seventh day after infection, one day after
the last dose.
+ Open protocol
+ Expand
10

Mouse Xenograft Model of Leukemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-to-seven week-old NOD/SCID/IL-2Rγnull mice (The Jackson Laboratory, Sacramento, CA, USA) were intravenously injected with parental, scramble, BMI1shRNA-transduced BV173 or SUP15 cells, or BMI1/BIM/E2F7shRNA-transduced BV173 cells (2×106 cells/mouse). Mice injected with parental cells were left untreated, while those injected with shRNA-BV173 or -SUP-B15 cells were continuously treated, starting 72 hours post-injection, with Doxy (2g/L) in D(+)-sucrose-supplemented (30g/L) drinking water to induce BMI1 or BMI1 and BIM downregulation in vivo.
Experiments were performed according to Animal Care and Use Committee’s guidelines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!